Brownstein B L, Rozengurt E, Jimenez de Asua L, Stoker M
J Cell Physiol. 1975 Jun;85(3):579-85. doi: 10.1002/jcp.1040850309.
Cytochalasin B was used as a tool to study the inter-relationships between cell movement, the reinitiated DNA synthesis and the enhanced transport of specific small molecules stimulated by serum in quiescent 3T3 cells. Cytochalasin at concentrations of less than 1 mug/ml inhibits serum-stimulated movement within the monolayer and migration into a wound. Even at ten times this concentration there is little effect on the increase in DNA in the culture, indicating that movement away from neighboring cells is not required for the initiation of DNA synthesis. While DNA synthesis is not inhibited by concentrations of cytochalasin up to 10 mug/ml, the increased thymidine transport which is associated with the onset of the S phase of the cell cycle is inhibited and DNA synthesis cannot be measured by the labelling of nuclei with radioactive thymidine. Cytochalasin has a differential effect on the early transport changes produced by serum addition. Glucose transport is inhibited by low concentrations of the drug (less than 1 mug/ml) while the enhanced uptake of phosphate and uridine is unaffected by a 10-fold increase in concentration. Although the doses of cytochalasin required for 50% inhibition of hexose uptake and of cell movement are the same, no causal relationship between sugar transport and locomotion can be demonstrated. Cytochalasin affects membrane functions in at least two different ways. The drug inhibits the uptake of glucose directly but affects only the S-phase associated increase in thymidine transport.
细胞松弛素B被用作一种工具,以研究静止的3T3细胞中细胞运动、重新启动的DNA合成以及血清刺激的特定小分子增强转运之间的相互关系。浓度低于1微克/毫升的细胞松弛素可抑制血清刺激的单层内细胞运动和向伤口的迁移。即使浓度是此浓度的十倍,对培养物中DNA增加的影响也很小,这表明DNA合成的起始并不需要与相邻细胞分离。虽然高达10微克/毫升的细胞松弛素浓度不会抑制DNA合成,但与细胞周期S期开始相关的胸苷转运增加受到抑制,并且无法通过用放射性胸苷标记细胞核来测量DNA合成。细胞松弛素对血清添加引起的早期转运变化具有不同的影响。低浓度(低于1微克/毫升)的该药物可抑制葡萄糖转运,而磷酸盐和尿苷摄取的增强不受浓度增加10倍的影响。尽管50%抑制己糖摄取和细胞运动所需的细胞松弛素剂量相同,但无法证明糖转运与运动之间存在因果关系。细胞松弛素至少以两种不同方式影响膜功能。该药物直接抑制葡萄糖摄取,但仅影响与S期相关的胸苷转运增加。